EUVIMEDEUVIMED entdecken
Crossref

Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis

Libin Xu, Siyu Li, Jiaxin Qi, Yan Mi, Ying Zhang, Yuxin Yang, Yingjie Wang, Di Zhou, Ning Li, Yue Hou

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2024.156253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Libin Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, National Frontiers Science Center f…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Inflammasomes, Ischemic Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Higher Education Discipline Innovation Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The significance of pyroptosis as an inflammatory mode of death in ischemic stroke (IS) has attracted much attention in recent years. Effusol is a dihydrophenanthrene component extracted from Juncus effusus L.. Previous studies have found that Juncus effusus L. has a good inhibitory effect against microglia activation. However, it is not clear whether effusol inhibits microglia over-activation and attenuates its mediated microglia pyroptosis in the treatment of IS. PURPOSE: The aim is to examine how effusol influences the initiation and activation stages of pyroptosis, as well as the NLRP3 inflammasome, resulting from microglial over-activation triggered post-IS. METHODS: This study investigated the impact of effusol on neurological severity and edema to assess its neuroprotective effects in IS. Mechanistically, immunofluorescence and western blotting were applied to explore the initiation and activation of the NLRP3 inflammasome. Finally, we employed the NLRP3 specific inhibitor, molecular docking, drug affinity responsive target stability (DARTS), and cellular thermal shift assay (CETSA) to further explore the underlying targets of effusol. RESULTS: Effusol mitigated IS-induced damage and downregulated the expression of inflammatory factors at the mRNA level, the protein levels of toll-like receptor 4 (TLR4), nuclear transcription factor NF-κB p65, and key components of the NLRP3 inflammasome. Effusol also mitigated mitochondrial damage by increasing ATP levels and decreasing mitochondrial membrane potential. Importantly, effusol targets NLRP3 protein to inhibit pyroptosis, thereby suppressing the hyperactivation of NLRP3 inflammasome. CONCLUSIONS: Effusol may be protective against IS by targeting NLRP3 proteins to inhibit NLRP3 inflammasome activation-mediated pyroptosis. This finding provides a theoretical basis and a prospective drug candidate for the treatment of effusol in IS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisInflammasomesIschemic StrokeNeuroprotective AgentsPhenanthrenesAnimalsMaleMiceMicrogliaMolecular Docking SimulationMice, Inbred C57BL

Stichwörter der Autor:innen

EffusolIschemic strokeMicrogliaNLRP3 inflammasomePyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, mouseNeuroprotective AgentsPhenanthrenes

Autor:innen und Institutionen

  • Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Key Laboratory of…
  • School of Traditional Chinese Materia Medica, Key Laboratory of Innovative Traditional Chinese Medicine for Major Chronic Diseases of Liaoning province, Key Laboratory for TCM Material Basis Study and Innovative Drug De…

Förderung

  • Fundamental Research Funds for the Central Universities
  • Higher Education Discipline Innovation Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Xu, L., Li, S., Qi, J., Mi, Y., Zhang, Y., Yang, Y., Wang, Y., Zhou, D., Li, N., & Hou, Y. (2025). Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156253

Vancouver

Xu L, Li S, Qi J, Mi Y, Zhang Y, Yang Y, et al. Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis. Phytomedicine. 2025. doi:10.1016/j.phymed.2024.156253

BibTeX
@article{Xu2025,
  author = {Xu, Libin and Li, Siyu and Qi, Jiaxin and Mi, Yan and Zhang, Ying and Yang, Yuxin and Wang, Yingjie and Zhou, Di and Li, Ning and Hou, Yue},
  title = {Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2024.156253}
}
Kostenlos starten →